The present invention relates to devices, arrangements and methods involving body fluid sampling and/or analysis. In certain embodiments, the present invention is directed to integrated monitoring and body fluid sampling devices and methods that are wearable, handheld, or easily converted for use in either manner.
In the discussion that follows, reference is made to certain structures and/or methods. However, the following references should not be construed as an admission that these structures and/or methods constitute prior art. Applicants expressly reserve the right to demonstrate that such structures and/or methods do not qualify as prior art.
According to the American Diabetes Association, diabetes is the fifth-deadliest disease in the United States and kills more than 213,000 people a year, the total economic cost of diabetes in 2002 was estimated at over $132 billion dollars. One out of every 10 health care dollars is spent on diabetes and its complications. The risk of developing type I juvenile diabetes is higher than virtually all other chronic childhood diseases. Since 1987 the death rate due to diabetes has increased by 45 percent, while the death rates due to heart disease, stroke, and cancer have declined.
A critical component in managing diabetes is frequent blood glucose monitoring. Currently, a number of systems exist for self-monitoring by the patient. Most fluid analysis systems, such as systems for analyzing a sample of blood for glucose content, comprise multiple separate components such as separate lancing, transport, and quantification portions. These systems are bulky, and often complicated and confusing for the user. These systems require significant user intervention. Current systems are not discreet, which, under certain social circumstances, may result in diabetics not monitoring their glucose levels.
Attempts have been made in the past to take steps toward automation of the testing process. Specifically, the Sof-Tact® System offered by Medisense in the early 2000s had the capability to test automatically at alternate sites without any user intervention, but only after each lancet and test strip had been manually loaded into the device. The device is configured for handheld operation only and is rather large. This meter is no longer available on the market.
A device similar to the Soft-Tact® device is disclosed in U.S. Patent Application Publication No. 2004/0138588 A1. This device attempts to integrate all the functions required to complete a glucose test into one device. This device however still requires the user to load a lancet and a test strip prior to each individual testing event. This device is also configured for handheld operation only.
This device is described in U.S. Patent Application Publication No. 2005/0010134 A1, and U.S. Pat. No. 6,793,633 B2 uses a spring, or motor driven mechanism to apply pressure around the target wound area. However, the device therein is not a fully integrated system. From the description it appears that the user must insert a new lancet and test strip assembly for each test. Another disadvantage of the device is configured only for handheld operation.
In summary, most current systems that are not integrated and thus involve many pieces that are not convenient and make the test difficult to perform discreetly. Other current devices that may be somewhat integrated but still require significant user intervention, are not discreet, and require more than one device to complete the test.
According to the present invention, there are provided body fluid sampling and monitoring devices and methods that may address one or more of the shortcomings noted above associated with conventional systems and devices. According to the present invention, there may also be provided improved monitoring and body fluid sampling devices and methods that permit handheld operation, wearable operation, and/or convertible for use in either manner.
One optional advantage of the invention over current devices is that it can be fully integrated and automated. The device can be packaged and designed such that it may be hand held or wearable, perhaps in the form of a wristwatch, and requires minimal or no intervention from the wearer in order to carry out testing, thus enhancing discreet testing. The invention also optionally enables an array of tests to be performed through use of a disposable cartridge or unit. For example, this system allows the user to load one cartridge that contains everything necessary for multiple tests. Another possible advantage of the invention is that it requires less body fluid for an accurate test than other systems currently available. This also facilitates reduction of pain experienced by the user during testing. The integrated nature of a device of the invention may also facilitate accurate tracking of blood glucose levels over time. Current systems rely on the user to test at specific intervals; a device constructed according to the principles of the present invention can be capable of testing independent of user input. A device of the present invention may optionally be constructed to give the user the option of automated/scheduled testing and/or on-demand testing.
It is to be understood that reference herein to first, second, third and fourth components (etc.) does not limit the present invention to embodiments where each of these components is physically separable from one another. For example, a single physical element of the invention may perform the features of more than one of the claimed first, second, third or fourth components. Conversely, a plurality of separate physical elements working together may perform the claimed features of one of the claimed first, second, third or fourth components. Similarly, reference to first, second (etc.) method steps does not limit the invention to only separate steps. According to the invention, a single method step may satisfy multiple steps described herein. Conversely, a plurality of method steps could, in combination, constitute a single method step recited herein.
According to another optional aspect of the present invention, there is provided an integrated body fluid sampling and analysis device, the device comprising a housing, the housing containing a plurality of body fluid sampling and analysis sites, each of the sites comprising a skin-penetration member, a body attachment element, and a quick release mechanism connecting the housing and the body attachment element.
According to a further optional aspect, the present invention provides an arrangement comprising a housing containing one or more components configured for at least one of body fluid sampling or analysis, and a body attachment element, wherein the housing and the body attachment element are connected by a quick-release mechanism configured to facilitate removal of the housing from the body attachment element.
According to yet another optional aspect, the present invention provides a method of performing at least one of body fluid sampling or analysis, the method comprising providing a housing with one or more components configured for at least one of body fluid sampling or analysis, the components comprising at least one skin-piercing member, providing a body attachment element, connecting the housing to the body attachment element in a releasable manner, removing the housing from the body attachment element, applying the housing to a surface of the skin, and piercing the skin with the at least one skin-penetration members.
As used herein “digital” means fingers or toes. “Digital body fluid” means expression of body fluid a wound created on the fingers or toes, and encompasses lancing sites on the dorsal or palm side of the distal finger tips.
As used herein “alternate-site” means a location on the body other than the digits, for example, the palm, forearm or thigh. “Alternate-site body fluid sampling” means expression of body fluid from the lancing site on a surface of the body other than the fingers or toes, and encompasses lancing sites on the palm, forearm, and thigh.
As used herein, “body fluid” encompasses whole blood, intestinal fluid, and mixtures thereof.
As used herein “integrated device” or “integrated meter” means a device or meter that includes all components necessary to perform sampling of body fluid, transport of body fluid, quantification of an analyte, and display of the amount of analyte contained in the sample of body fluid.
The following description of preferred embodiments can be read in connection with the accompanying drawings in which like numerals designate like elements and in which:
Exemplary arrangements and methods for the detection and measurement of the presence and/or concentration of a target analyte, such as glucose, bilirubin, alcohol, controlled substances, toxins, hormones, proteins, etc., will now be described.
According to certain embodiments, the current device is a fully integrated, electromechanical system or device used in the sampling and/or analysis of a bodily fluid. One possible body fluid is whole blood and one possible analyte is glucose. The fully integrated device of the present invention is much smaller than any current commercially available semi-integrated, or multi-piece glucose testing system, using blood as the analyte. The fully integrated nature of the invention reduces the total number of parts a user must carry to complete a test from about a minimum of 3-8 (lancet, lancer, test strip, calibration fluid, alcohol wipe, carrying case, etc.) to 1-2 pieces (integrated device, optional carrying case). A fully integrated device formed according to the present invention requires little or no user intervention to carry out testing. For example, the device may automatically perform testing at predetermined intervals. Alternatively, the integrated device can offer automatic single button operation that significantly reduces the level of dexterity required for operation compared with currently available systems. The device of the present invention may comprise a reusable unit and a disposable unit comprising a plurality of test subsystems. The device or system may be wearable or may be hand held. The reusable portion of the device may include a housing, an attachment mechanism, and a user interface display. It may include an energy storage system, mechanisms to facilitate the testing process including motors, vacuum pumps, and mechanical stored energy systems. The reusable unit or portion may also include microprocessors, and other electronics in support of analyte quantification. The reusable portion may also include optical systems for analyte quantification. The reusable unit may include mechanisms for indexing between multiple test sites, and may also include user interface devices such as buttons, knobs, and microphones. The device or system of the present invention may also include a disposable portion. The disposable portion may include an array of skin piercing elements attached to guides, triggers and/or actuation mechanisms. The disposable portion may also include mechanisms for transporting a sample of body fluid from the skin surface into other areas of the device. According to certain embodiments, at least a portion of the transport operation is integrated into the skin-piercing element. The disposable portion may also include analyte quantification members that may be separate from or integrated with the transport member. The analyte quantification members may be designed to optically or electrochemically indicate detectable signals when exposed to the analyte of interest.
The disposable portion may also include a skin-interfacing member, possibly a soft silicone footprint. The skin interfacing member can optionally be constructed of any material that facilitates sample acquisition via conditioning the skin prior to, during and/or after piercing. The skin interface may be included in the reusable portion of the device.
The disposable portion may include an energy source. The disposable portion may also include a housing designed to enclose, and/or seal the analyte quantification members. The disposable portion may also include mechanisms, or be designed to allow for user-adjustable skin piercing depth. The disposable portion may also include vacuum chambers as well as a means to provide an airtight seal against the skin.
An integrated device or meter of the type described above is illustrated in
According to the present invention, it is possible, but not mandatory, to form the integrated device with a low height profile to make the device as compact and discreet as possible. Thus, according to the present invention, the actuator can be designed to accelerate the skin-piercing element along a curved or rotational path. This construction provides for a more compact height profile of the device. Any suitable mechanism for accelerating the needle along a curved or rotational path is contemplated. One such mechanism is a torsional spring element. The integrated device or meter 10 also includes a housing 16 formed of any suitable material. One or more actuation posts, or triggers, 18 are fixably mounted to a base plate 20 such that each one individually constrains a spring actuator 22 in a cocked position such that the spring is in such a state that it stores elastic energy. Skin piercing elements 24, which may be in the form of lancets or hollow needles, are mounted over the one or more actuation posts 18. Upon release of a trigger element 18 the skin piercing element 24 is driven into the skin of the user or wearer. The trigger may be released by one of a variety of different physical means. The trigger may be a bimetallic strip that, when heated, deforms enough so that the spring retainer clears the trigger and is released. The trigger may alternatively be a fuse such that when current is passed through it, it breaks causing the actuator to be released. The device or arrangement 10 may be constructed such that each individual skin-piercing element 24 is provided with its own actuator 22. Optionally, the actuator 22 may be provided in the form of a torsional spring, as illustrated.
The actuator spring elements 22 may be provided to the user in a pre-cocked position, as illustrated in
Another advantage of this aspect of the present invention is that the actuator torsional spring elements 22 do not require a positive stop to limit the penetration depth of the skin-piercing element 24. It has been observed that elimination of a hard stop may provide certain beneficial effects. Namely, it has been observed that devices that include a hard stop experience a shock and resulting vibration and/or stirring action when the stop is impacted. It is theorized that this motion may increase the observable wound and/or the perceived pain associated with sampling. According to this embodiment, the depth of penetration of the skin-penetrating member 24 is determined by a number of factors, including the design of the sharp, the actuation force and the skin's resistance to penetration at the chosen sampling site, and the height that the skin is raised up (if any) by application of a vacuum catalyst.
When the skin piercing element 24 is in the form of a needle having an inner passageway or lumen 24l, an analyte quantification member 26 that may comprise an assay pad 28 is provided in communication with the lumen 24l of the needle such that the quantification member can receive a sample of blood produced by the piercing of the user's skin with the needle. The quantification member 26 can be in optical communication with a detector array 30 that reads a color change on the assay pad or can be an electrochemical means according to an alternative embodiment.
One possible modification of the arrangement 10 is illustrated in
Another possible modification of the arrangement 10 is illustrated in
According to certain embodiments of the present invention, a single actuator mechanism (e.g., a motor) can index to drive one or more selected skin piercing members that form part of an array into the skin (see, e.g.,
According to alternative embodiments of the present invention, certain actuators that are contemplated can cause the driven skin-piercing element (or needle) to rapidly oscillate, re-enter or repeatedly penetrate the skin at the sampling site. The number of penetrations per actuation or sampling event can vary between 2-20 times. The frequency of oscillation of the skin-piercing element may vary and can be on the order of 200-600 Hz. It has been observed that such oscillation does not appear to produce an increase in the observable wound or perceived pain by the user. The skin-piercing element may be driven at any suitable speed.
The invention described herein suggests that the skin-piercing member can be driven into the skin by some controlled force. There are several embodiments of actuators that can perform this function including torsional springs, compression springs, cantilever beams, linear voice coils/solenoids, pneumatic cylinders, as well as others. A torsional spring embodiment has been described above. Additional, exemplary embodiments of such actuators are illustrated in
An additional alternative embodiment is illustrated in
A further alternative embodiment of the present invention is illustrated in
The driving element may be another type of actuator besides a beam such as, a coil spring, solenoid, voice coil, or any other type of mechanism that can accelerate to enough momentum to impact or push the skin-piercing element such that it penetrates the skin to the proper depth.
An additional illustrative embodiment is depicted in
Another alternative embodiment uses small stepper motors that rotate to release a latch. Specifically a small stepper motor is attached to a rotating or flexible “arm” feature, as that arm rotates it contacts a latch, knocks it off of its rest point and releases the spring.
Yet another embodiment uses a nitinol switch that changes shape when current is applied to it. As the shape of the trigger changes the actuator is released. According to a further embodiment, a breakable wire switch works on the concept that some materials weaken when exposed to heat or current. A small section of this material would be used to hold the actuator in the cocked position. To release the actuator, a current is passed through the wire. Similarly, heat can be applied to a thread-like material or other material to sever the material by melting or burning.
According to the present invention, additional skin penetration element embodiments are envisioned. For example, several possible orientations for one or more bevel(s) formed at the end of a skin penetration element or member, such as a lancet or needle are contemplated. Four such alternatives are illustrated in
Three additional alternative arrangements for producing a sample of blood or body fluid by piercing the surface of the skin, while minimizing the wound created therein, are illustrated in
As illustrated in
According to the arrangement 120, the skin-piercing element 122 and the actuation member 124 are configured and arranged such that the path of travel of the end of the skin piercing element 122 after entry into the skin is not too shallow along its radius of travel. In other words, according to one embodiment, the skin piercing element 122 and the actuation member 124 are configured and arranged such that the path of travel of the end of the skin piercing element 122 after entry into the skin is closer to the perpendicular, or a wider arc, as opposed to a travel path that is more parallel to the surface of the skin 126.
An alternative arrangement 130 is depicted in
A further alternative arrangement 140 is depicted in
While a wearable integrated meter has several advantages over current technology it is understood that there may be times when the user is either unable or would prefer not to wear the integrated meter. Examples of such situations include during exercise, swimming, sleeping, or when social situations where the style of the watch may be inappropriate. Thus, the present invention also advantageously comprises a wearable meter that can be converted into a handheld meter.
The compact size of the integrated devices of the present invention allows the user to carry everything necessary to complete a test in a small pocket. For example, if a user needed to attend a formal dinner they most likely will not have space to carry all of the components associated with currently available glucose testing systems. These users will likely take a health risk and ignore testing during the event. The size of the integrated devices of the present invention allows the user to carry the entire device in their pocket and test discreetly in a restroom, or even beneath the table on their lap.
Integrated wearable devices according to the present invention that can be converted to a hand held device also allow the user to test at a digit or the fingertip if needed or desired. While testing at an alternate site such as the wrist is safe and accepted during certain hypoglycemic incidents, it is still advantageous for the user to be able to test at the finger to get an even more accurate glucose reading. Also, regardless of increased pain and other factors, some users may prefer to test at a digit or the fingers regularly and only occasionally wear the device for convenience. The present invention provides for such usage.
The following features facilitate usage of convertible hand held integrated devices formed according to the present invention. Thus, an integrated device formed according to the present invention may also include one or more of the following features.
According to one embodiment, the device is provided with a footprint comprising a single opening for testing. The user operates the device upside down by placing their fingertip on top of the footprint, or the user operates the device face side up and locates their fingertip under the footprint. For upside-down operation the device may have alerts that are not visible, for example tactile (vibrations, heat, etc.), or audible alerts. These alerts can be used to inform the user that a test is about to begin and to notify the user that a test is complete. To further simplify operation the device can have an “on-demand finger test” trigger on the device. This trigger will allow the user to initiate a test without having to look at the top face of the device. For example, the user may remove the watch from their wrist press a button or combination of buttons that place the system into finger test mode. In this state, the finger test trigger would be in the active state. The user could then turn over the device and use it without looking at the topside of the device. Potential triggers include buttons, pressure sensors, capacitive sensors and other commonly known input mechanisms. It is also possible to have the finger trigger activate as soon as it detects that a finger is placed on it for a set period of time. This will eliminate the need to change the device to “finger mode”, thereby simplifying the testing process. Another embodiment comprises a footprint having multiple openings that can be used to complete a finger test, and allows the user to complete a test while still looking at the top face of the device. With this construction, the user will have to correctly identify the opening upon which to place their finger. Several features are contemplated to assist with testing in this manner.
The top face of the device can have features that point the user to the proper location for the current test. Such features can be visible indicators, such as LED's, around the perimeter of the device that correspond to each opening in the footprint. For example, before a test the corresponding LED will illuminate, guiding the user to the correct position under the device.
Visual indicators, such as the above-mentioned LED's, can also be used below the device to illuminate the targeted sampling site and allow the user to correctly position the device. These LED's would have the added benefit of allowing the user to correctly place the device in a poorly lit environment. Another feature for guiding the user to the correct location for a test is to have the display of the device display an arrow that points to the correct position or opening in the footprint for a test.
Each footprint can include a sensor (pressure, switch, capacitive, thermal, etc.) to determine that a finger is present. The device would be able to fire any of the actuators at anytime, so when the user places their finger under an opening in the footprint, an actuator would fire and a test would be completed. If the user placed their finger under an opening in the footprint that had already been used, the device could detect that and tell the user to move their finger to another site.
According to a further alternative, certain openings in the footprint may be reserved for finger testing. These openings would be easily identifiable by site or touch, allowing the user to accurately position their finger for a test.
In one embodiment, a device such as the one illustrated in
Alternative embodiments of the present invention are illustrated in
One such suitable quick release mechanism 164 is illustrated in
Another alternative quick release mechanism is illustrated in
According to a further embodiment, the quick release mechanism 164 may take the form of that illustrated in
An arrangement constructed according to a further alternative embodiment of the present invention is illustrated in
As an alternative to the separate case 192, a similar protective feature or features may be integrated into the device 152. For example, the device 152 is separated from the band 162, the device 152 may be provided with a rotatable plastic shield 193, which can be rotated into a position which covers the openings 160 in the footprint 158. When the user is ready to use the device, the plastic shield 193 is rotated again until the openings 160 and footprint 158 are accessible. According to a further alternative, a plastic shield 193 can be configured such that it will cover all but one of the openings 160. This enables the entire device to be evacuated and the remaining open footprint sealed against the user's skin, such as by application of a vacuum. This embodiment advantageously facilitates the use of a vacuum in conjunction with sampling, and eliminates the need to isolate each individual chamber against vacuum leaks.
A further alternative embodiment of the present invention is illustrated in
In order to facilitate use of the handheld device for finger testing, the handheld device 206, or the separate case 202, may be provided with a feature for accurately positioning the finger for testing such as footprint area 208 which may include a groove or channel in which the user can lay their finger. The device can be designed such that the unit then rotates until an available test site is aligned with the opening disposed in the recess or channel in registry with the users finger.
Certain modes of operation of an integrated device or meter of the type described herein are also contemplated by the present invention.
Before any testing can occur the user opens all the packaging and inserts a disposable unit into the wearable or hand held device. The disposable portion or unit may be attached via several mechanical methods including threads, screws, snaps, etc.
After a disposable is loaded, the device prepares itself to initiate a test. Preparations may include reading the calibration codes on the disposable portion, measuring a controlled calibration fluid, and/or other self checks. During startup the device may also prompt the user to schedule test intervals. The user should now place the device on their body, possibly the wrist, optionally using an attachment means.
When it is time for a scheduled test, or the user requests a test, the device begins test preparations. The device may give user an indication that a test is imminent; the indication may be visual, audible, tactile or a combination of indicators. If necessary, the device will index to the next available test setup location. The indexing may be via a motor driven mechanism or stored mechanical energy. The device may now cock the skin piercing member. The device may now test to ensure skin contact. The device may now initiate a catalyst process. Catalyst processes are intended to increase fluid sample availability and production at the sampling site.
At this point a trigger releases the actuation mechanism and drives the skin piercing member into the skin.
After piercing the skin the device begins to transport the fluid or blood to the quantification media. Once the sample arrives at the quantification media, a reaction occurs. This reaction is measured to produce an analyte reading. Once a sufficient sample volume is delivered to the quantification media, the catalyst process may be terminated. The device may now output a reading to the user. When it is time for the next test the process is repeated. If the testing fails, the device may automatically repeat a test. The device will inform the user of remaining number of tests. When all tests are used the device will prompt user to load a fresh disposable unit.
According to one illustrative embodiment of the present invention, an integrated device is operated according to the state diagram contained in
1) A start switch closure starts off the sequence.
2) The vacuum pump turns on.
3) When the vacuum set point is reached, the vacuum is maintained for a vacuum hold period (nominally set to 5 seconds). This catalyst increases blood production to a practical/usable amount.
4) The trigger releases the sharp immediately after the “vacuum hold” is completed.
5) A spring settling delay state allows the spring to settle in a fixed position before the CMOS sensor can read parameters required for K/S calculation and subsequent glucose levels. This delay does not start until the trigger is released. The reasons for this is that the release of the trigger could potentially move the assay pad and produce an unwanted spatial error on the black or white reference signals.
6) A black read is performed, typically with the reagent LED illumination extinguished.
7) The reagent LED illumination is then turned on.
8) A white read is done.
9) The scanning wet read puts the CMOS image results into a database.
10) The vacuum is released upon acquisition of a sufficient volume of sample detected by the CMOS image detector.
11) A K/S and/or glucose concentration calculation then takes place.
12) The reporting state displays the result of the above calculation or any errors that may exist.
13) Several errors can be trapped, and in most cases, abort the sequence. Such errors include things like insufficient vacuum, loss of vacuum, unexpected white read value and other user aborts.
14) The glucose concentration is not displayed until the chamber is within 0.5 in. Hg. This keeps blood from blowing unnecessarily into the chamber, thus requiring a major cleanup.
15) The last state simply waits for the next start button closure.
It should be understood, that consistent with the principles of the present invention and in connection with the exemplary mode of operation illustrated in
An exemplary body fluid sampling and analysis methodology or technique, which may be utilized in conjunction with any of the above-mentioned devices or integrated meters, but is not necessarily limited thereto, is described as follows.
A user loads a fresh disposable cartridge containing a plurality of skin penetration members and analysis sites into an integrated meter. The integrated meter then reads calibration data contained in or on the cartridge. This data can be read in any suitable manner. For example, a bar code may be placed on the cartridge which can be optically read by the optical assembly contained within the meter. The integrated meter then selects the proper lookup table or algorithm to calculate an aggregate glucose measurement taking into consideration the calibration data. The meter may then place itself in a ready mode waiting for a trigger to initiate sampling and testing. The user then either manually presses a button or trigger to initiate sampling and analysis, or the device verifies that it is properly positioned on the skin of the user and ready to begin the sampling and analysis procedure. Suitable sensors to accomplish this include optical, capacitive or pressure sensors. The device then initiates a catalyst which acts to facilitate the expression of body fluid. According to one alternative embodiment, the catalyst is an inflatable member that exerts pressure on a digit. Alternatively, the catalyst is vacuum pressure which generates suction at the sampling site. Sensors present in the meter may be used to monitor and control the positive or negative pressure of the catalyst. After achieving a target pressure for a desired period of time, the skin penetration member (e.g., a hollow needle) is actuated and driven into the skin of the user to create a wound site. The skin penetration member comes to rest in or directly on the wound created at the sampling site where it is in the desired position for collecting a sample of body fluid expressed from the wound. The integrated meter may further include a mechanism for detecting a whether a sufficient amount of sample has been expressed. Details of such suitable detection techniques are described in detail in U.S. Pat. No. 7,052,652, entitled ANALYTE CONCENTRATION DETECTION DEVICES AND METHODS, the entire content of which is incorporated herein by reference. Once the desired amount of body fluid has been obtained, the catalyst may be deactivated. A sample of body fluid is in fluid communication with a device or mechanism which creates a detectable signal upon reaction within analyte present in the sample body fluid. For example, one such suitable mechanism is a absorbent pad containing a chemical reagent which, upon reaction with the analyte produces a reaction spot which can be optically detected. An optical assembly which is in optical communication with the above described signal generating mechanism is utilized to detect the signal created via reaction with the analyte and communicate the signals to supporting electronics contained within the meter. The concentration of a target analyte (e.g., glucose) can then be calculated using these signals as a basis. Additional factors may be considered during these calculations, such as the sample size, levels of other substances contained in the sample (e.g. hematocrit), etc. Such optional calculation techniques are described in further detail in U.S. patent application Ser. No. 11/239,122, entitled ANALYTE DETECTION DEVICES AND METHODS WITH HEMATOCRIT/VOLUME CORRECTION AD FEEDBACK CONTROL, the entire content of which is incorporated herein by reference. These calculations quantify the amount of analyte contained in the sample body fluid. This quantity is displayed on a suitable display contained within the meter which can be easily read by the user. The integrated meter then automatically indexes the disposable cartridge to present a fresh unused skin penetration member which will be utilized to perform the next sampling and analysis event.
Numbers expressing quantities of ingredients, constituents, reaction conditions, and so forth used in this specification are to be understood as being modified in all instances by the term “about”. Notwithstanding that the numerical ranges and parameters setting forth, the broad scope of the subject matter presented herein are approximations, the numerical values set forth are indicated as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective measurement techniques. None of the elements recited in the appended claims should be interpreted as invoking 35 U.S.C. §112, 16, unless the term “means” is explicitly used.
Although the present invention has been described in connection with preferred embodiments thereof, it will be appreciated by those skilled in the art that additions, deletions, modifications, and substitutions not specifically described may be made without department from the spirit and scope of the invention as defined in the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
842690 | Oswalt | Jan 1907 | A |
D137874 | Partridge | May 1944 | S |
2749797 | Harks | Mar 1950 | A |
3092465 | Adams, Jr. | Jun 1963 | A |
3310002 | Wilburn | Mar 1967 | A |
3620209 | Kravitz | Nov 1971 | A |
3623475 | Sanz et al. | Nov 1971 | A |
3626929 | Sanz et al. | Dec 1971 | A |
3630957 | Rey | Dec 1971 | A |
D223165 | Komendat | Mar 1972 | S |
3723064 | Liotta | Mar 1973 | A |
3741197 | Sanz et al. | Jun 1973 | A |
3961898 | Neeley et al. | Jun 1976 | A |
4014328 | Cluff et al. | Mar 1977 | A |
4042335 | Clement | Aug 1977 | A |
4057394 | Genshaw | Nov 1977 | A |
4109655 | Chacornac | Aug 1978 | A |
4254083 | Columbus | Mar 1981 | A |
4258001 | Pierce et al. | Mar 1981 | A |
4260257 | Neeley et al. | Apr 1981 | A |
4289459 | Neeley et al. | Sep 1981 | A |
4321397 | Nix et al. | Mar 1982 | A |
4350762 | DeLuca et al. | Sep 1982 | A |
4394512 | Batz | Jul 1983 | A |
4414975 | Ryder et al. | Nov 1983 | A |
4418037 | Katsuyama et al. | Nov 1983 | A |
4422941 | Vaughan, Jr. et al. | Dec 1983 | A |
4429700 | Thees et al. | Feb 1984 | A |
4627445 | Garcia et al. | Dec 1986 | A |
4637403 | Garcia et al. | Jan 1987 | A |
4637406 | Guinn et al. | Jan 1987 | A |
4653513 | Dombrowski | Mar 1987 | A |
4702261 | Cornell et al. | Oct 1987 | A |
4711250 | Gilbaugh, Jr. et al. | Dec 1987 | A |
4737458 | Batz et al. | Apr 1988 | A |
4767415 | Duffy | Aug 1988 | A |
4774192 | Terminiello et al. | Sep 1988 | A |
4790979 | Terminiello et al. | Dec 1988 | A |
4794926 | Munsch et al. | Jan 1989 | A |
4815843 | Tiefenthaler et al. | Mar 1989 | A |
4829470 | Wang | May 1989 | A |
4846785 | Cassou et al. | Jul 1989 | A |
4887306 | Hwang et al. | Dec 1989 | A |
4920977 | Haynes | May 1990 | A |
4930525 | Palestrant | Jun 1990 | A |
4935346 | Phillips et al. | Jun 1990 | A |
4953552 | DeMarzo | Sep 1990 | A |
4966646 | Zdeblick | Oct 1990 | A |
4995402 | Smith et al. | Feb 1991 | A |
5029583 | Meserol et al. | Jul 1991 | A |
5049487 | Phillips et al. | Sep 1991 | A |
5050617 | Columbus et al. | Sep 1991 | A |
5059394 | Phillips et al. | Oct 1991 | A |
5077199 | Basagni et al. | Dec 1991 | A |
5094943 | Siedel et al. | Mar 1992 | A |
5116759 | Klainer et al. | May 1992 | A |
5131404 | Neeley et al. | Jul 1992 | A |
5141868 | Shanks et al. | Aug 1992 | A |
5145565 | Kater et al. | Sep 1992 | A |
5146437 | Boucheron | Sep 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5164575 | Neeley et al. | Nov 1992 | A |
5166498 | Neeley | Nov 1992 | A |
5174291 | Schoonen et al. | Dec 1992 | A |
5176632 | Bernardi | Jan 1993 | A |
5179005 | Phillips et al. | Jan 1993 | A |
5183741 | Arai et al. | Feb 1993 | A |
5196302 | Kidwell | Mar 1993 | A |
5208163 | Charlton et al. | May 1993 | A |
5213966 | Vuorinen et al. | May 1993 | A |
5217480 | Habar et al. | Jun 1993 | A |
5218966 | Yamasawa | Jun 1993 | A |
5223219 | Subramanian et al. | Jun 1993 | A |
5234818 | Zimmermann et al. | Aug 1993 | A |
5241969 | Carson et al. | Sep 1993 | A |
5251126 | Kahn et al. | Oct 1993 | A |
D341848 | Bigelow et al. | Nov 1993 | S |
5275159 | Griebel | Jan 1994 | A |
5278079 | Gubinski et al. | Jan 1994 | A |
5288646 | Lundsgaard et al. | Feb 1994 | A |
5299571 | Mastrototaro | Apr 1994 | A |
5301686 | Newman | Apr 1994 | A |
5302513 | Miike et al. | Apr 1994 | A |
5304468 | Phillips et al. | Apr 1994 | A |
5306623 | Kiser et al. | Apr 1994 | A |
5308767 | Terashima | May 1994 | A |
5320607 | Ishibashi | Jun 1994 | A |
5354537 | Moreno | Oct 1994 | A |
5360595 | Bell et al. | Nov 1994 | A |
5368047 | Suzuki et al. | Nov 1994 | A |
5383512 | Jarvis | Jan 1995 | A |
5390671 | Lord et al. | Feb 1995 | A |
5399316 | Yamada | Mar 1995 | A |
5401110 | Neeley | Mar 1995 | A |
5402798 | Swierczek et al. | Apr 1995 | A |
5441513 | Roth | Aug 1995 | A |
5451350 | Macho et al. | Sep 1995 | A |
5458140 | Eppstein et al. | Oct 1995 | A |
5460777 | Kitajima et al. | Oct 1995 | A |
5460968 | Yoshida et al. | Oct 1995 | A |
5482473 | Lord et al. | Jan 1996 | A |
5506200 | Hirschkoff et al. | Apr 1996 | A |
5507288 | Böcker et al. | Apr 1996 | A |
5508200 | Tiffany et al. | Apr 1996 | A |
5510266 | Bonner et al. | Apr 1996 | A |
5514152 | Smith | May 1996 | A |
5568806 | Cheney, II et al. | Oct 1996 | A |
5569287 | Tezuka et al. | Oct 1996 | A |
5575403 | Charlton et al. | Nov 1996 | A |
5577499 | Teves | Nov 1996 | A |
5582184 | Erickson et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5591139 | Lin et al. | Jan 1997 | A |
5611809 | Marshall et al. | Mar 1997 | A |
5624458 | Lipscher | Apr 1997 | A |
5630986 | Charlton et al. | May 1997 | A |
5632410 | Moulton et al. | May 1997 | A |
5636632 | Bommannan et al. | Jun 1997 | A |
5647851 | Pokras | Jul 1997 | A |
5658515 | Lee et al. | Aug 1997 | A |
5660791 | Brenneman et al. | Aug 1997 | A |
5676850 | Reed et al. | Oct 1997 | A |
5680858 | Hansen et al. | Oct 1997 | A |
5681484 | Zanzucchi et al. | Oct 1997 | A |
5682233 | Brinda | Oct 1997 | A |
5697901 | Eriksson | Dec 1997 | A |
5701181 | Boiarski et al. | Dec 1997 | A |
5701910 | Powles et al. | Dec 1997 | A |
5705018 | Hartley | Jan 1998 | A |
5708787 | Nakano et al. | Jan 1998 | A |
5715417 | Gardien et al. | Feb 1998 | A |
5730753 | Morita | Mar 1998 | A |
5735273 | Kurnik et al. | Apr 1998 | A |
5736103 | Pugh | Apr 1998 | A |
5741211 | Renirie et al. | Apr 1998 | A |
5746217 | Erickson et al. | May 1998 | A |
5746720 | Stouder, Jr. | May 1998 | A |
5757666 | Schreiber et al. | May 1998 | A |
5759364 | Charlton et al. | Jun 1998 | A |
5766066 | Ranniger | Jun 1998 | A |
5771890 | Tamada | Jun 1998 | A |
5797693 | Jaeger | Aug 1998 | A |
5801057 | Smart et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5820570 | Erickson et al. | Oct 1998 | A |
5827183 | Kurnik et al. | Oct 1998 | A |
5840020 | Heinonen et al. | Nov 1998 | A |
5841126 | Fossum et al. | Nov 1998 | A |
5843692 | Phillips et al. | Dec 1998 | A |
5846837 | Thym et al. | Dec 1998 | A |
5854074 | Charlton et al. | Dec 1998 | A |
D403975 | Douglas et al. | Jan 1999 | S |
5855801 | Lin et al. | Jan 1999 | A |
5856195 | Charlton et al. | Jan 1999 | A |
5858194 | Bell | Jan 1999 | A |
5866281 | Guckel et al. | Feb 1999 | A |
5871494 | Simons et al. | Feb 1999 | A |
5879310 | Sopp et al. | Mar 1999 | A |
5879326 | Godshall et al. | Mar 1999 | A |
5879367 | Latterell et al. | Mar 1999 | A |
5891053 | Sesekura | Apr 1999 | A |
5893870 | Talen et al. | Apr 1999 | A |
5911711 | Pelkey | Jun 1999 | A |
5911737 | Lee et al. | Jun 1999 | A |
5912139 | Iwata et al. | Jun 1999 | A |
5925021 | Castellano et al. | Jul 1999 | A |
5928207 | Pisano et al. | Jul 1999 | A |
5930873 | Wyser | Aug 1999 | A |
5938679 | Freeman et al. | Aug 1999 | A |
5945678 | Yanagisawa | Aug 1999 | A |
5951492 | Douglas et al. | Sep 1999 | A |
5951521 | Mastrototaro et al. | Sep 1999 | A |
5954685 | Tierney | Sep 1999 | A |
5962215 | Douglas et al. | Oct 1999 | A |
5968760 | Phillips et al. | Oct 1999 | A |
5968765 | Grage et al. | Oct 1999 | A |
5971941 | Simons et al. | Oct 1999 | A |
5972294 | Smith et al. | Oct 1999 | A |
5986754 | Harding | Nov 1999 | A |
5989409 | Kurnik et al. | Nov 1999 | A |
5993189 | Mueller et al. | Nov 1999 | A |
6001067 | Shults et al. | Dec 1999 | A |
6005545 | Nishida et al. | Dec 1999 | A |
6010463 | Lauks et al. | Jan 2000 | A |
6010519 | Mawhirt et al. | Jan 2000 | A |
6014135 | Fernandes | Jan 2000 | A |
6014577 | Henning et al. | Jan 2000 | A |
6023629 | Tamada | Feb 2000 | A |
6027459 | Shain et al. | Feb 2000 | A |
6030827 | Davis et al. | Feb 2000 | A |
6032059 | Henning et al. | Feb 2000 | A |
6036924 | Simons et al. | Mar 2000 | A |
6041253 | Kost et al. | Mar 2000 | A |
6050988 | Zuck | Apr 2000 | A |
6056701 | Duchon et al. | May 2000 | A |
6056734 | Jacobsen et al. | May 2000 | A |
6058321 | Swayze et al. | May 2000 | A |
6059815 | Lee et al. | May 2000 | A |
6061128 | Zweig et al. | May 2000 | A |
6063039 | Cunningham et al. | May 2000 | A |
6071251 | Cunningham et al. | Jun 2000 | A |
6071294 | Simons et al. | Jun 2000 | A |
6077660 | Wong et al. | Jun 2000 | A |
6080116 | Erickson et al. | Jun 2000 | A |
6083196 | Trautman et al. | Jul 2000 | A |
6086544 | Hibner et al. | Jul 2000 | A |
6090790 | Eriksson | Jul 2000 | A |
6091975 | Daddona et al. | Jul 2000 | A |
6093156 | Cunningham et al. | Jul 2000 | A |
6097831 | Wieck et al. | Aug 2000 | A |
6099484 | Douglas et al. | Aug 2000 | A |
6100107 | Lei et al. | Aug 2000 | A |
6102933 | Lee et al. | Aug 2000 | A |
6103033 | Say et al. | Aug 2000 | A |
6103197 | Werner | Aug 2000 | A |
6106751 | Talbot et al. | Aug 2000 | A |
6118126 | Zanzucchi | Sep 2000 | A |
6120676 | Heller et al. | Sep 2000 | A |
6123861 | Santini, Jr. et al. | Sep 2000 | A |
6126899 | Woudenberg et al. | Oct 2000 | A |
6132449 | Lum et al. | Oct 2000 | A |
6139562 | Mauze et al. | Oct 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6152942 | Brenneman et al. | Nov 2000 | A |
6162639 | Douglas | Dec 2000 | A |
6175752 | Say et al. | Jan 2001 | B1 |
6176865 | Mauze et al. | Jan 2001 | B1 |
6183434 | Eppstein | Feb 2001 | B1 |
6183489 | Douglas et al. | Feb 2001 | B1 |
6187210 | Lebouiz et al. | Feb 2001 | B1 |
6192891 | Gravel et al. | Feb 2001 | B1 |
6200296 | Dibiasi et al. | Mar 2001 | B1 |
6206841 | Cunningham et al. | Mar 2001 | B1 |
6214626 | Meller et al. | Apr 2001 | B1 |
6219574 | Cormier et al. | Apr 2001 | B1 |
6228100 | Schraga | May 2001 | B1 |
6230051 | Cormier et al. | May 2001 | B1 |
6231531 | Lum et al. | May 2001 | B1 |
6241862 | McAleer et al. | Jun 2001 | B1 |
6242207 | Douglas et al. | Jun 2001 | B1 |
6245215 | Douglas et al. | Jun 2001 | B1 |
6251083 | Yum et al. | Jun 2001 | B1 |
6251260 | Heller et al. | Jun 2001 | B1 |
6254586 | Mann et al. | Jul 2001 | B1 |
6255061 | Mori et al. | Jul 2001 | B1 |
6256533 | Yuzhakov et al. | Jul 2001 | B1 |
6268162 | Phillips et al. | Jul 2001 | B1 |
6271045 | Douglas et al. | Aug 2001 | B1 |
6272364 | Kurnik | Aug 2001 | B1 |
6283926 | Cunningham et al. | Sep 2001 | B1 |
6289230 | Chaiken et al. | Sep 2001 | B1 |
6298254 | Tamada | Oct 2001 | B2 |
6299578 | Kurnik et al. | Oct 2001 | B1 |
6309351 | Kurnik et al. | Oct 2001 | B1 |
D450711 | Istvan et al. | Nov 2001 | S |
6312612 | Sherman et al. | Nov 2001 | B1 |
6312888 | Wong et al. | Nov 2001 | B1 |
6322808 | Trautman et al. | Nov 2001 | B1 |
6329161 | Heller et al. | Dec 2001 | B1 |
6331266 | Powell et al. | Dec 2001 | B1 |
6332871 | Douglas et al. | Dec 2001 | B1 |
6334856 | Allen et al. | Jan 2002 | B1 |
6350273 | Minagawa et al. | Feb 2002 | B1 |
6352514 | Douglas et al. | Mar 2002 | B1 |
6356776 | Berner et al. | Mar 2002 | B1 |
6358265 | Thorne et al. | Mar 2002 | B1 |
6364890 | Lum et al. | Apr 2002 | B1 |
6375626 | Allen et al. | Apr 2002 | B1 |
6375627 | Mauze et al. | Apr 2002 | B1 |
6379969 | Mauze et al. | Apr 2002 | B1 |
6391005 | Lum et al. | May 2002 | B1 |
6409679 | Pyo | Jun 2002 | B2 |
6428664 | Bhullar et al. | Aug 2002 | B1 |
6449608 | Morita et al. | Sep 2002 | B1 |
6455324 | Douglas | Sep 2002 | B1 |
6500134 | Cassone | Dec 2002 | B1 |
6520973 | McGarry | Feb 2003 | B1 |
6530892 | Kelly | Mar 2003 | B1 |
6537243 | Henning et al. | Mar 2003 | B1 |
6540675 | Aceti et al. | Apr 2003 | B2 |
6544475 | Douglas et al. | Apr 2003 | B1 |
6555061 | Leong et al. | Apr 2003 | B1 |
6558624 | Lemmon et al. | May 2003 | B1 |
6579690 | Bonnecaze et al. | Jun 2003 | B1 |
6602205 | Erickson et al. | Aug 2003 | B1 |
6612111 | Hodges et al. | Sep 2003 | B1 |
6616616 | Fritz et al. | Sep 2003 | B2 |
6626874 | Duchamp | Sep 2003 | B1 |
6656167 | Numao et al. | Dec 2003 | B2 |
6706049 | Moerman | Mar 2004 | B2 |
6706159 | Moerman et al. | Mar 2004 | B2 |
6740800 | Cunningham | May 2004 | B1 |
6748275 | Lattner et al. | Jun 2004 | B2 |
6753187 | Cizdziel et al. | Jun 2004 | B2 |
6766817 | da Silva | Jul 2004 | B2 |
6793633 | Douglas et al. | Sep 2004 | B2 |
6830669 | Miyazaki et al. | Dec 2004 | B2 |
6836678 | Tu | Dec 2004 | B2 |
6837858 | Cunningham et al. | Jan 2005 | B2 |
6847451 | Pugh | Jan 2005 | B2 |
6918404 | Dias da Silva | Jul 2005 | B2 |
6919960 | Hansen et al. | Jul 2005 | B2 |
6923764 | Aceti et al. | Aug 2005 | B2 |
6936476 | Anderson et al. | Aug 2005 | B1 |
6988996 | Roe et al. | Jan 2006 | B2 |
7004928 | Aceti et al. | Feb 2006 | B2 |
7025774 | Freeman et al. | Apr 2006 | B2 |
7052652 | Zanzucchi et al. | May 2006 | B2 |
7066586 | da Silva | Jun 2006 | B2 |
7066890 | Lam et al. | Jun 2006 | B1 |
7141058 | Briggs et al. | Nov 2006 | B2 |
7156809 | Quy | Jan 2007 | B2 |
7192061 | Martin | Mar 2007 | B2 |
D540343 | Cummins et al. | Apr 2007 | S |
7223365 | Freiherr Von Der Goltz | May 2007 | B2 |
7225008 | Ward et al. | May 2007 | B1 |
7226461 | Boecker et al. | Jun 2007 | B2 |
7258673 | Racchini et al. | Aug 2007 | B2 |
D551243 | Young | Sep 2007 | S |
7270970 | Anderson et al. | Sep 2007 | B2 |
7297151 | Boecker et al. | Nov 2007 | B2 |
7343188 | Sohrab | Mar 2008 | B2 |
7344507 | Briggs et al. | Mar 2008 | B2 |
7427377 | Zanzucchi et al. | Sep 2008 | B2 |
D599373 | Kobayashi et al. | Sep 2009 | S |
D601578 | Poulet et al. | Oct 2009 | S |
7803123 | Perez et al. | Sep 2010 | B2 |
7887494 | Emery et al. | Feb 2011 | B2 |
D642191 | Barnett et al. | Jul 2011 | S |
8012103 | Escutia et al. | Sep 2011 | B2 |
8012104 | Escutia et al. | Sep 2011 | B2 |
20010001034 | Douglas | May 2001 | A1 |
20010027328 | Lum et al. | Oct 2001 | A1 |
20010053891 | Ackley | Dec 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020002344 | Douglas et al. | Jan 2002 | A1 |
20020004640 | Conn et al. | Jan 2002 | A1 |
20020006355 | Whitson | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020020688 | Sherman et al. | Feb 2002 | A1 |
20020023852 | Mcivor et al. | Feb 2002 | A1 |
20020042594 | Lum et al. | Apr 2002 | A1 |
20020052618 | Haar et al. | May 2002 | A1 |
20020087056 | Aceti et al. | Jul 2002 | A1 |
20020136667 | Subramanian et al. | Sep 2002 | A1 |
20020137998 | Smart et al. | Sep 2002 | A1 |
20020160520 | Orloff et al. | Oct 2002 | A1 |
20020169394 | Eppstein et al. | Nov 2002 | A1 |
20020169411 | Sherman et al. | Nov 2002 | A1 |
20020177761 | Orloff et al. | Nov 2002 | A1 |
20020183102 | Withers et al. | Dec 2002 | A1 |
20020188223 | Perez et al. | Dec 2002 | A1 |
20020198444 | Uchigaki et al. | Dec 2002 | A1 |
20030012693 | Otillar et al. | Jan 2003 | A1 |
20030028087 | Yuzhakov et al. | Feb 2003 | A1 |
20030028125 | Yuzhakov et al. | Feb 2003 | A1 |
20030039587 | Niermann | Feb 2003 | A1 |
20030083685 | Freeman et al. | May 2003 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030116596 | Terasawa | Jun 2003 | A1 |
20030135166 | Gonnelli | Jul 2003 | A1 |
20030135333 | Aceti et al. | Jul 2003 | A1 |
20030153844 | Smith et al. | Aug 2003 | A1 |
20030153900 | Aceti et al. | Aug 2003 | A1 |
20030175987 | Verdonk et al. | Sep 2003 | A1 |
20030206302 | Pugh | Nov 2003 | A1 |
20030207441 | Eyster et al. | Nov 2003 | A1 |
20030208113 | Mault et al. | Nov 2003 | A1 |
20030211619 | Olson et al. | Nov 2003 | A1 |
20030212344 | Yuzhakov et al. | Nov 2003 | A1 |
20030212347 | Sohrab | Nov 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040030353 | Schmelzeisen-Redeker et al. | Feb 2004 | A1 |
20040049219 | Briggs et al. | Mar 2004 | A1 |
20040059256 | Perez | Mar 2004 | A1 |
20040073140 | Douglas et al. | Apr 2004 | A1 |
20040092842 | Boecker et al. | May 2004 | A1 |
20040092995 | Boecker et al. | May 2004 | A1 |
20040096959 | Stiene et al. | May 2004 | A1 |
20040098009 | Boecker et al. | May 2004 | A1 |
20040102803 | Boecker et al. | May 2004 | A1 |
20040122339 | Roe | Jun 2004 | A1 |
20040132167 | Rule et al. | Jul 2004 | A1 |
20040138588 | Saikley et al. | Jul 2004 | A1 |
20040155084 | Brown | Aug 2004 | A1 |
20040178218 | Schomakers et al. | Sep 2004 | A1 |
20040186394 | Roe et al. | Sep 2004 | A1 |
20040191119 | Zanzucchi et al. | Sep 2004 | A1 |
20040202576 | Aceti et al. | Oct 2004 | A1 |
20040236251 | Roe et al. | Nov 2004 | A1 |
20040238675 | Banaszkiewicz et al. | Dec 2004 | A1 |
20050010134 | Douglas et al. | Jan 2005 | A1 |
20050015020 | LeVaughn et al. | Jan 2005 | A1 |
20050096686 | Allen | May 2005 | A1 |
20050106713 | Phan et al. | May 2005 | A1 |
20050159678 | Taniike et al. | Jul 2005 | A1 |
20050187532 | Thurau et al. | Aug 2005 | A1 |
20050202567 | Zanzucchi et al. | Sep 2005 | A1 |
20050202733 | Yoshimura et al. | Sep 2005 | A1 |
20050215872 | Berner et al. | Sep 2005 | A1 |
20050215923 | Wiegel | Sep 2005 | A1 |
20050245844 | Mace et al. | Nov 2005 | A1 |
20050277972 | Wong et al. | Dec 2005 | A1 |
20060008389 | Sacherer et al. | Jan 2006 | A1 |
20060036134 | Tarassenko et al. | Feb 2006 | A1 |
20060117616 | Jones et al. | Jun 2006 | A1 |
20060135873 | Karo et al. | Jun 2006 | A1 |
20060155317 | List | Jul 2006 | A1 |
20060189908 | Kennedy | Aug 2006 | A1 |
20060204399 | Freeman et al. | Sep 2006 | A1 |
20060229533 | Hoenes et al. | Oct 2006 | A1 |
20060241517 | Fowler et al. | Oct 2006 | A1 |
20060257993 | McDevitt et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060281187 | Emery et al. | Dec 2006 | A1 |
20070017824 | Rippeth et al. | Jan 2007 | A1 |
20070078313 | Emery et al. | Apr 2007 | A1 |
20070078358 | Escutia et al. | Apr 2007 | A1 |
20070083131 | Escutia et al. | Apr 2007 | A1 |
20070179404 | Escutia et al. | Aug 2007 | A1 |
20070179405 | Emery et al. | Aug 2007 | A1 |
20070255181 | Alvarez-Icaza et al. | Nov 2007 | A1 |
20070255302 | Koeppel et al. | Nov 2007 | A1 |
20080077048 | Escutia et al. | Mar 2008 | A1 |
20090156923 | Power et al. | Jun 2009 | A1 |
20100021948 | Lipman et al. | Jan 2010 | A1 |
20100185120 | Sacherer et al. | Jul 2010 | A1 |
Number | Date | Country |
---|---|---|
199 22 413 | Nov 2000 | DE |
103 02 501 | Aug 2004 | DE |
0 396 016 | Nov 1990 | EP |
0 396 016 | Nov 1990 | EP |
0 255 338 | Feb 1998 | EP |
1 266-607 | Dec 2002 | EP |
1 266-607 | Dec 2002 | EP |
1 360 934 | Nov 2003 | EP |
1 360 934 | Nov 2003 | EP |
1 486 766 | Dec 2004 | EP |
1 486 766 | Dec 2004 | EP |
1 529-489 | May 2005 | EP |
1 529-489 | May 2005 | EP |
1 769 735 | Apr 2007 | EP |
63-305841 | Dec 1988 | JP |
3-63570 | Mar 1991 | JP |
03093189 | Apr 1991 | JP |
7-67861 | Mar 1995 | JP |
7-213925 | Aug 1995 | JP |
9-168530 | Jun 1997 | JP |
9-313465 | Sep 1997 | JP |
9-266889 | Oct 1997 | JP |
9-294737 | Nov 1997 | JP |
10 024028 | Jan 1998 | JP |
10-318970 | Dec 1998 | JP |
2000126161 | May 2000 | JP |
2000-254111 | Sep 2000 | JP |
2001-159618 | Jun 2001 | JP |
2001-515203 | Sep 2001 | JP |
2001-305096 | Oct 2001 | JP |
2001-330581 | Nov 2001 | JP |
2002-502045 | Jan 2002 | JP |
2004-000598 | Jan 2004 | JP |
2004-522500 | Jul 2004 | JP |
2005-503538 | Feb 2005 | JP |
2005-087613 | Apr 2005 | JP |
2005-237938 | Sep 2005 | JP |
2005-527254 | Sep 2005 | JP |
2006-512969 | Apr 2006 | JP |
2006-512974 | Apr 2006 | JP |
2006-516723 | Jul 2006 | JP |
2006-521555 | Sep 2006 | JP |
2006-527013 | Nov 2006 | JP |
2007-521031 | Aug 2007 | JP |
WO-9413203 | Jun 1994 | WO |
WO-9510223 | Apr 1995 | WO |
WO-9510223 | Apr 1995 | WO |
WO-9604857 | Feb 1996 | WO |
WO-9614026 | May 1996 | WO |
WO-9625088 | Aug 1996 | WO |
WO-9715227 | May 1997 | WO |
WO-9729847 | Aug 1997 | WO |
WO-9730344 | Aug 1997 | WO |
WO-9741421 | Nov 1997 | WO |
WO-9831275 | Jul 1998 | WO |
WO-9835225 | Aug 1998 | WO |
WO-9912008 | Mar 1999 | WO |
9944508 | Sep 1999 | WO |
WO-0009184 | Feb 2000 | WO |
WO-0013573 | Mar 2000 | WO |
WO-0014269 | Mar 2000 | WO |
WO-0014535 | Mar 2000 | WO |
WO-0018449 | Apr 2000 | WO |
WO-0018449 | Apr 2000 | WO |
WO-0036400 | Jun 2000 | WO |
WO-0042422 | Jul 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0078208 | Dec 2000 | WO |
WO-0116575 | Mar 2001 | WO |
WO-0152727 | Jul 2001 | WO |
0164105 | Sep 2001 | WO |
WO-0172220 | Oct 2001 | WO |
WO-0180728 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0191634 | Dec 2001 | WO |
WO-0191634 | Dec 2001 | WO |
0200101 | Jan 2002 | WO |
0249507 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02093144 | Nov 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-03030984 | Apr 2003 | WO |
WO 03071940 | Sep 2003 | WO |
WO-2004062499 | Jul 2004 | WO |
WO-2004062500 | Jul 2004 | WO |
WO-2004-062500 | Jul 2004 | WO |
WO-2004064636 | Aug 2004 | WO |
WO-2005006939 | Jan 2005 | WO |
WO-2005006939 | Jan 2005 | WO |
WO-2005009238 | Feb 2005 | WO |
WO-2005-084543 | Sep 2005 | WO |
WO-2005084546 | Sep 2005 | WO |
WO-2005085995 | Sep 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20070179404 A1 | Aug 2007 | US |
Number | Date | Country | |
---|---|---|---|
60721966 | Sep 2005 | US |